Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/26788
Title: First co-infection of malaria and hepatitis E diagnosed in Sri Lanka
Authors: Senarathne, S.
Rajapakse, S.
de Silva, H.J.
Seneviratne, S.
Chulasiri, P.
Fernando, D.
Keywords: malaria
hepatitis E
co-infections
Issue Date: 2023
Publisher: Sri Lanka Medical Association
Citation: Sri Lanka Medical Association, 136th Anniversary International Medical Congress. 2023; 68 (Supplement S):S101
Abstract: INTRODUCTION: Imported malaria cases continue to be reported in Sri Lanka. Similarly, hepatitis E is also considered a travel associated imported disease in Sri Lanka. This is a report of the first co-infection of malaria and hepatitis E in Sri Lanka. OBJECTIVES: A 21-year-old European who visited Sri Lanka after a 2 months stay in India, was admitted to hospital with fever, vomiting, abdominal pain, and dark-coloured urine on the 4th day after his arrival. On examination, he had splenomegaly but no hepatomegaly. He had thrombocytopaenia; 89% neutrophils; 9% lymphocytes; elevated liver enzymes and hyperbilirubinaemia. Urine was positive for bile pigment. METHODS: Considering his travel history to India, he was tested for malaria. The rapid diagnostic test became positive for Plasmodium falciparum while microscopy showed P. falciparum ring stages with a parasite density of 120/μl. He was treated as for uncomplicated P. falciparum malaria with oral Artemisinin-based Combination Therapy. The patient became fever-free and blood smears became negative after 13 hours following 2 doses of antimalarials. RESULTS: However, his liver functions were further deranged with apparent jaundice (ALT: 250 U/L; AST: 175 U/L; ALP: 130 U/L; GGT: 179 U/L; total bilirubin: 10.65 mg/dL; direct bilirubin: 8.08 mg/dL; indirect bilirubin: 2.57 mg/dL). Further blood tests detected hepatitis E-specific IgM antibodies. He was treated with oral ursodiol but no specific antiviral was given. Following the completion of antimalarials, he was discharged from the hospital upon clinical recovery. CONCLUSION: Clinicians should be vigilant on travel-associated co-infections in patients who are diagnosed with imported malaria.
Description: Poster Presentation Abstract (PP 049), 136th Anniversary International Medical Congress, Sri Lanka Medical Association, 25th-28th July 2023, Colombo, Sri Lanka
URI: http://repository.kln.ac.lk/handle/123456789/26788
ISSN: 0009-0875
Appears in Collections:Conference Papers

Files in This Item:
File Description SizeFormat 
Abstract-book-2023-FINAL-VERSION-2.0-101.pdf519.17 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.